The information contained in this section of the EuropaBio website intends to provide operators who are handling GM commodities in the EU with a list of GM products currently authorised for import and use in the Community according to Directive 2001/18/EC and/or Regulation (EC) No 1829/2003 and which are subject to General Surveillance.

For each GM product, an extensive documentation on the product, together with a copy of the relevant EFSA opinion(s) and Commission Decision(s), is provided once the product is authorised in the European Community.

The GM products present in this list are subject to General Surveillance provisions, as foreseen by Directive 2001/18/EC and/or Regulation (EC) No 1829/2003. The consent/authorisation holder is responsible to report the results of General Surveillance on an annual basis and, in case an adverse effect is identified, to inform immediately the appropriate authority.

The aim of General Surveillance is to identify any potential adverse effect of the GM product towards human and animal health and the environment, which has not been anticipated in the environmental risk assessment. General surveillance is based on routine observation primarily by the people and networks having regular contact with the environment where the GM product is handled, processed and used. Operators, with their expertise in handling commodities, are therefore in the best position to report to the consent/authorisation holder any observed potential adverse effect of GM products.